MBCL-36. HOW TO INCREASE SURVIVAL IN 7 TO 10% OF PATIENTS WITH AVERAGE-RISK MEDULLOBLASTOMA WITHOUT NEW THERAPIES: EARLY PROSPECTIVE NEURORADIOLOGY SCREENING EXPERIENCE FROM THE CHILDREN’S ONCOLOGY GROUP

Authors: Nicholas Gottardo, Sarah Leary, Guolian Kang, Jeffrey Gossett, Maryam Fouladi, Sandy Kessel, Noah Sabin, Alok Jaju, Julie Harreld

Published: 2020-12-04

DOI: 10.1093/neuonc/noaa222.512

Source: Full article


Abstract

Abstract